FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

CADILAHC Share Price Discussion

Cadila Healthcare Ltd.
NSE: CADILAHC | BSE: 532321 | ISIN: INE010B01027 | Sector: Pharmaceuticals and health care
Find answers to all your questions on live CADILAHC message board: Is CADILAHC buy or sell? Should I buy CADILAHC shares? Why are CADILAHC shares falling? Should I invest in CADILAHC stock?

You can also check CADILAHC share price target recommended by brokerages.

BRIEF-Cadila Healthcare Gets Warning Letter Issued By US FDA Relating To Moraiya Formulation Facility - Reuters
04-Nov-2019 02:36:01 PM
Nov 4 (Reuters) - Cadila Healthcare Ltd CADI.NS:
. - WARNING LETTER - US FDA
SAYS COMPANY HAS RECEIVED A WARNING LETTER ISSUED BY US FDA RELATING TO ITS MORAIYA FORMULATION FACILITY.
WARNING LETTER RELATING TO ITS MORAIYA FORMULATION FACILITY
WILL CONTINUE TO TAKE NECESSARY STEPS TO ENSURE THAT US FDA IS FULLY SATISFIED WITH REMEDIATION OF ABOVE FACILITY
CONFIDENT OF RESPONDING TO US FDA TO ADDRESS THE OBSERVATIONS WITHIN THE STATUTORY TIME
CADILA HEALTHCARE -WARNING LETTER DOES NOT AFFECT EXISTING BUSINESS OF CO IN US AND THE EXISTING PRODUCT SUPPLIES FROM MORAIYA FACILITY TO CONTINUE.
Like
reply
Reply
Recent posts in CADILAHC
@researcheducation • Reputation: -63,717

INTRADAY & POSITIONAL
CADILA BUY
ABOVE 272
STOP LOSS 267
TARGETS 276 280 284 ++
Like
reply
Reply
@newsbot • Reputation: 2,570
Cadila, Ipca gain 4-9% after US allows emergency use of antimalarial drugs for COVID-19
Cadila Healthcare and Ipca Labs are prominent manufacturers of hydroxychloroquine and chloroquine in India. Both are antimalarial drugs.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,570
Cadila Healthcare share price rises over 2% on USFDA approval to Zydus for Parkinson's drug
The drug will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,570
Zydus Cadila gets tentative nod from USFDA for Parkinson's treatment capsule
The approval by the US Food and Drug Administration is for Carbidopa and Levodopa extended-release capsules in the strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and 61.25 mg/245 mg, Cadila Healthcare said in a regulatory filing.
Moneycontrol
Like
reply
Reply
@100billionclub • Reputation: 2,107

BUY CADILAHC ABV 256
Like
reply
Reply (1)
@deep-r16Zfg58I • Reputation: -80
CADILAHC

Type
Buy
Instrument
CADILAHC
Entry Price
₹256
Price@Trade
₹256.5
Target Price
₹290
Stop Price
₹250
Valid Till
Mar 30, 2020 3:20 AM
Margin
₹256 approx for 1 Qty
Status
Validity Over
Exit Price
₹252.3
Net P&L
-1.45% Loss
Like
reply
Reply (2)